MedTrace Logo

VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)

NCT06694766 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2025-12-15

No results posted yet for this study

Summary

The aim of this study is to compare the immunogenicity induced by yellow fever vaccination administered during pregnancy with that induced by vaccination outside pregnancy, and to assess the maternal and fetal tolerance of this vaccination.

Conditions

  • Yellow Fever Vaccine

Interventions

PROCEDURE

Blood sample collection

A blood sample collection of 18.5 mL will be required for the immunogenicity component.

Sponsors & Collaborators

  • Cerballiance

    collaborator UNKNOWN

  • Institut Pasteur

    lead INDUSTRY

Principal Investigators

  • Kaoutar JIDAR, MD · Medical Center of l'Institut Pasteur (CMIP)

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-24
Primary Completion
2028-03-31
Completion
2030-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06694766 on ClinicalTrials.gov